Akcea Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 34 U.S.-traded ETFs. AKCA has around 2.4M shares in the U.S. ETF market. The largest ETF holder of AKCA is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.04M shares. Investors may also find of interest that the ETF with the largest allocation to AKCA stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.10%. On average, U.S. ETFs allocate 0.16% of AKCA to their portfolios.
Additionally, AKCA is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AKCA as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.